Zimmer Biomet (ZBH) Stock
Global maker of joint replacement and spinal implants. Here's the price, business snapshot, and what's worth knowing about Zimmer Biomet in September 2026.
Zimmer Biomet Holdings, Inc. (ZBH) is a global medical‑device company specialising in musculoskeletal healthcare — primarily joint replacement, spinal and dental solutions. With a market capitalisation around $20.3bn, it serves hospitals, surgeons and clinics through product sales, aftermarket services and implants. Key growth drivers include ageing populations, increasing demand for elective orthopaedic procedures and geographic expansion in emerging markets. Investors should watch procedure volumes, product mix, pricing pressure, merger and acquisition activity and reimbursement trends — these affect revenue and margins. The business is also exposed to regulatory, litigation and supply‑chain risks that can affect performance. Financially, margins can improve with scale and operational efficiency, but outcomes vary by cycle and region. This summary is educational and not personalised investment advice; shares can fall as well as rise. Consider your objectives and risk tolerance or consult a regulated adviser before acting.
Zimmer Biomet (ZBH) Stock Forecast
Analyst price target, next 12 months
$120.26
+33.4% vs today's $90.13
Price range over the last 12 months
In the middle of its 12-month range
Analysts covering Zimmer Biomet have a consensus 12-month target of $120.26, above the current price of $90.13.
Analyst targets are opinions, not guarantees. Capital at risk. Data as of 24 Sep 2026.
Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.
Sixth Month Growth Performance
Stock Performance Snapshot
Analyst Rating
Analysts suggest keeping Zimmer Biomet's stock as it may rise to a target price of $120.26.
Financial Health
Zimmer Biomet is achieving strong revenue and profits while maintaining healthy cash flow levels.
Dividend
Zimmer Biomet's dividend yield of 1.07% is below average, which may not attract dividend-focused investors. If you invested $1000, you would be paid $9.60 a year in dividends (based on the last 12 months).
Why You’ll Want to Watch This Stock
Aging population demand
An older population supports long‑term demand for joint replacements and related care, though procedure cycles and reimbursement can cause variability.
Global market exposure
Broad geographic presence can fuel growth as emerging markets adopt advanced care, but it also brings currency, regulatory and supply‑chain risks.
R&D and margins
Innovation and product mix can lift margins over time, yet investment cycles and competitive pricing pressure mean outcomes are uncertain.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
